Clinical Trial Update: A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports that SNDX-5613 is being studied in combination with intensive chemotherapy for acute myeloid leukemia, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• SNDX-5613

Snippet

Sponsor: Syndax Pharmaceuticals | Conditions: Acute Myeloid Leukemias | Phase 1 | Status: RECRUITING